Schedule 13G ownership disclosure

KITE PHARMA INC COM

Security class unavailable · CUSIP: 49803L109

Event date: 2016-02-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,441,232
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001103804-16-000109
Form type
SC 13G
Filer
Kite Pharma, Inc.
CIK
CIK 1510580
Filed
Feb 29, 2016
Reporting period
Feb 18, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub